NEW DELHI: The final approval for Bharat Biotech’s Covaxin for children aged 2-18 years is under experts’ opinion and evaluation, stated government sources on Thursday. Sources said after evaluation of the data, the final approval will be given by the Drug Controller General of India (DCGI). Bharat Biotech in an official statement had said they are waiting for further approvals from drug regulators. This is one of the first worldwide approval for Covid-19 vaccines for the age group of beneficiaries.